Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Nephrology
Volume 2012 (2012), Article ID 573650, 5 pages
http://dx.doi.org/10.1155/2012/573650
Case Report

Development of Renal Failure without Proteinuria in a Patient with Monoclonal Gammopathy of Undetermined Significance: An Unusual Presentation of AL Kappa Amyloidosis

Division of Nephrology, Raymond G. Murphy Veterans Affairs Medical Center, The University of New Mexico School of Medicine and VA Medical Center (111C), 1501 San Pedro SE, Albuquerque, NM 87108, USA

Received 31 August 2012; Accepted 23 September 2012

Academic Editors: C. Garcia, C. I. Obialo, A. K. Saxena, and S. Zerbi

Copyright © 2012 Yijuan Sun et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Mollee, “Current trends in the diagnosis, therapy and monitoring of the monoclonal gammopathies,” The Clinical Biochemist Reviews, vol. 30, no. 3, pp. 93–103, 2009. View at Google Scholar
  2. R. A. Kyle, T. M. Therneau, S. V. Rajkumar et al., “Prevalence of monoclonal gammopathy of undetermined significance,” New England Journal of Medicine, vol. 354, no. 13, pp. 1362–1369, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. R. A. Kyle, T. M. Therneau, S. Vincent Rajkumar et al., “A long-term study of prognosis in monoclonal gammopathy of undetermined significance,” New England Journal of Medicine, vol. 346, no. 8, pp. 564–569, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Y. Kristinsson, M. Björkholm, T. M. L. Andersson et al., “Patterns of survival and causes of death following a diagnosis of monoclonal gammopathy of undetermined significance: a population-based study,” Haematologica, vol. 94, no. 12, pp. 1714–1720, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. J. P. Bida, R. A. Kyle, T. M. Therneau et al., “Disease associations with monoclonal gammopathy of undetermined significance: a population-based study of 17,398 patients,” Mayo Clinic Proceedings, vol. 84, no. 8, pp. 685–693, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Paueksakon, M. P. Revelo, R. G. Horn, S. Shappell, and A. B. Fogo, “Monoclonal gammopathy: significance and possible causality in renal disease,” American Journal of Kidney Diseases, vol. 42, no. 1, pp. 87–95, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Dispenzieri, J. A. Katzmann, R. A. Kyle et al., “Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study,” The Lancet, vol. 375, no. 9727, pp. 1721–1728, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Morel-Maroger, A. Basch, F. Danon, P. Verroust, and G. Richet, “Pathology of the kidney in Waldenström's macroglobulinemia. Study of sixteen cases,” New England Journal of Medicine, vol. 283, no. 3, pp. 123–129, 1970. View at Google Scholar · View at Scopus
  9. J. Lima, M. Monteagudo, M. Valles, F. Garcia-Bragado, M. Carrera, and M. Vilardell, “Proliferative endo- and extracapillary glomerulonephritis and benign monoclonal IGM gammopathy,” Nephron, vol. 56, no. 4, pp. 457–458, 1990. View at Google Scholar · View at Scopus
  10. C. Rollino, R. Coppo, G. Mazzucco et al., “Monoclonal gammopathy and glomeulonephritis with organized microtubular deposits,” American Journal of Kidney Diseases, vol. 15, no. 3, pp. 276–280, 1990. View at Google Scholar · View at Scopus
  11. A. R. Esparza, J. A. Chazan, R. N. Nayak, and T. Cavallo, “Fibrillary (immunotactoid) glomerulopathy: a possible role for kappa light chain in its etiology and/or pathogenesis,” American Journal of Surgical Pathology, vol. 15, no. 7, pp. 632–643, 1991. View at Google Scholar · View at Scopus
  12. H. G. Rennke, “Secondary membranoproliferative glomerulonephritis,” Kidney International, vol. 47, no. 2, pp. 643–656, 1995. View at Google Scholar
  13. A. Dysseleer, L. Michaux, J. P. Cosyns, E. Goffin, C. Hermans, and Y. Pirson, “Benign monoclonal gammopathy turning to AL amyloidosis after kidney transplantation,” American Journal of Kidney Diseases, vol. 34, no. 1, pp. 166–169, 1999. View at Google Scholar · View at Scopus
  14. J. Lin, G. S. Markowitz, A. M. Valeri et al., “Renal monoclonal immunoglobulin deposition disease: the disease spectrum,” Journal of the American Society of Nephrology, vol. 12, no. 7, pp. 1482–1492, 2001. View at Google Scholar · View at Scopus
  15. G. S. Markowitz, M. P. Zdunek, and V. D. D'Agati, “Nephrotic syndrome, renal insufficiency, and a monoclonal gammopathy,” American Journal of Kidney Diseases, vol. 38, no. 5, pp. 1135–1140, 2001. View at Google Scholar · View at Scopus
  16. T. Nagao, T. Okura, K. I. Miyoshi et al., “Fibrillary glomerulonephritis associated with monoclonal gammopathy of undetermined significance showing lambda-type Bence Jones protein,” Clinical and Experimental Nephrology, vol. 9, no. 3, pp. 247–251, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Hashimoto, K. Arakawa, Y. Ohta et al., “Acquired fanconi syndrome with osteomalacia secondary to monoclonal gammopathy of undetermined significance,” Internal Medicine, vol. 46, no. 5, pp. 241–245, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Sundaram, R. Mainali, E. R. Norfolk, J. H. Shaw, and P. L. Zhang, “Case report: fibrillary glomerulopathy secondary to light chain deposition disease in a patient with monoclonal gammopathy,” Annals of Clinical and Laboratory Science, vol. 37, no. 4, pp. 370–374, 2007. View at Google Scholar · View at Scopus
  19. T. Okura, K. I. Miyoshi, T. Nagao et al., “Light chain deposition disease developing 15 years following the diagnosis of monoclonal gammopathy of undetermined significance,” Internal Medicine, vol. 48, no. 2, pp. 101–104, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. I. M. Hii, M. L. Chen, and C. C. Chang, “Benign monoclonal gammopathy-associated acute kidney injury: case report and literature review,” Renal Failure, vol. 32, no. 5, pp. 636–638, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. S. de Seigneux, P. Bindi, H. Debiec et al., “Immunoglobulin deposition disease with a membranous pattern and a circulating monoclonal immunoglobulin G with charge-dependent aggregation properties,” American Journal of Kidney Diseases, vol. 56, no. 1, pp. 117–121, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Sethi, L. Zand, N. Leung et al., “Membranoproliferative glomerulonephritis secondary to monoclonal gammopathy,” Clinical Journal of the American Society of Nephrology, vol. 5, no. 5, pp. 770–782, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Sethi, W. R. Sukov, Y. Zhang et al., “Dense deposit disease associated with monoclonal gammopathy of undetermined significance,” American Journal of Kidney Diseases, vol. 56, no. 5, pp. 977–982, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. P. Stratta, L. Gravellone, T. Cena et al., “Renal outcome and monoclonal immunoglobulin deposition disease in 289 old patients with blood cell dyscrasias: a single center experience,” Critical Reviews in Oncology/Hematology, vol. 79, no. 1, pp. 31–42, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. F. Bidoux, S. Desport, V. Fremeaux-Bacchi et al., “Glomerulonephritis with isolated C3 deposits and monoclonal gammopathy: a fortuitous association?” Clinical Journal of the American Society of Nephrology, vol. 6, no. 9, pp. 2165–2174, 2011. View at Google Scholar
  26. L. Valdez-Boyle, P. Adams, D. Wheeler, D. Malhotra, M. Pierdy, and A. H. Tzamaloukas, “Renal amyloidosis presenting as interstitial nephritis,” Clinical Nephrology, vol. 50, no. 4, pp. 268–269, 1998. View at Google Scholar · View at Scopus
  27. H. M. Falck, T. Tornroth, and O. Wegelius, “Predominantly vascular amyloid deposition in the kidney in patients with minimal or no proteinuria,” Clinical Nephrology, vol. 19, no. 3, pp. 137–142, 1983. View at Google Scholar · View at Scopus
  28. H. Uda, A. Yokota, K. Kobayashi et al., “Two distinct clinical courses of renal involvement in rheumatoid patients with AA amyloidosis,” Journal of Rheumatology, vol. 33, no. 8, pp. 1482–1487, 2006. View at Google Scholar · View at Scopus
  29. V. Bellotti, G. Merlini, E. Bucciarelli, V. Perfetti, S. Quaglini, and E. Ascari, “Relevance of class, molecular weight and isoelectric point in predicting human light chain amyloidogenicity,” British Journal of Haematology, vol. 74, no. 1, pp. 65–69, 1990. View at Google Scholar · View at Scopus